Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)

China flag China · Delayed Price · Currency is CNY
53.23
-0.71 (-1.32%)
At close: Feb 26, 2026
Market Cap2.06B +62.1%
Revenue (ttm)165.86M -6.8%
Net Income-5.47M
EPS-0.14
Shares Out38.78M
PE Ration/a
Forward PEn/a
Dividend0.30 (0.56%)
Ex-Dividend DateNov 26, 2025
Volume402,546
Average Volume483,325
Open54.29
Previous Close53.94
Day's Range53.01 - 54.29
52-Week Range30.60 - 60.60
Beta0.29
RSI55.56
Earnings DateApr 29, 2026

About SHA:688193

Shanghai Rendu Biotechnology Co., Ltd. engages in the research, development, production, and sales of RNA molecular diagnostic technology and products. It offers products in the areas of reproductive health, bloodborne infections, respiratory infections, enterovirus infections, cancer early detection, and other areas; and AutoSAT, SuperSAT, and ultrasonic homogenizer. The company was founded in 2007 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2007
Employees 290
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688193
Full Company Profile

Financial Performance

Financial Statements